Prognostic prediction of primary biliary cirrhosis and therapy monitoring with ursodeoxycholic acid
10.3760/cma.j.issn.1009-9158.2016.02.004
- VernacularTitle:原发性胆汁性肝硬化预后与治疗监测
- Author:
Yan LIANG
;
Zaixing YANG
;
Renqian ZHONG
;
Lin ZHOU
- Publication Type:Journal Article
- Keywords:
Liver Cirrhosis,Biliary;
Ursodeoxycholic Acid;
Prognosis;
Treatment Outcome;
Severity of Illness Index
- From:
Chinese Journal of Laboratory Medicine
2016;39(2):82-84
- CountryChina
- Language:Chinese
-
Abstract:
Primary biliary cirrhosis (PBC) is a chronic cholestic autoimmune liver disease and ursodeoxycholic acid (UDCA) is the first-line drug for the treatment.Currently there are several standards applied for the prognostic and therapeutic predictions of PBC,as well as for the guidance of personalized treatment.This paper elucidated the prognostic predicting factors in PBC and their applications in therapy monitoring with UDCA.Current challenges and future research interests are also put forward.
